Business
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.
Tom Little | Reuters
Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027, in a bid to make the treatments more accessible to patients with insurance coverage.
The obesity injection Wegovy, its new pill counterpart, the diabetes shot Ozempic and the oral diabetes drug Rybelsus will have a new lower list price of $675 per month starting on Jan. 1, 2027. The Wegovy medicines both currently have list prices of around $1,350 per month, while the diabetes drugs have list prices of around $1,027 per month.
For the first time, Novo said its price cuts are targeting insured patients whose out-of-pocket costs are linked to list prices, such as people with high-deductible health plans or co-insurance benefit designs.
“Both of these patient populations should, beginning [in 2027], see a benefit with lower out-of-pocket burdens,” Jamey Millar, the company’s head of U.S. operations, told CNBC in an interview.
He added that Novo expects improvements in access and uptake among patients in the commercial insurance market, though the company is not giving any specific expectations.
The move could help Novo compete better with Eli Lilly, which now holds the majority share in the blockbuster GLP-1 market. Lilly’s more effective drugs and earlier foray into the direct-to-consumer space have allowed it to take the lead in the space, but the company has yet to significantly lower the U.S. list prices of its medicines.
It’s unclear exactly how much commercial insured patients typically pay out of pocket for Novo’s drugs. Those patients may pay as little as $25 per month for Novo’s drugs in “only the best of circumstances,” Millar said.
But patients in high-deductible plans would have to pay out-of-pocket “more or less the full list price of a drug until they reach that” threshold and the insurance benefit kicks in, he added. Millar said some of those patients defer treatment entirely because they don’t want to shoulder that expense. The number of patients using high-deductible plans has increased over the years due to the trade-off of lower premiums, he noted.
Meanwhile, Millar said other people have 25% to 33% of their co-insurance linked to the list prices of those drugs.
The Danish drugmaker has previously cut the direct-to-consumer prices of Wegovy and Ozempic, which primarily benefit cash-paying patients who often don’t have insurance coverage for the drugs.
Novo offers its drugs to cash-paying patients for $149 to $499 per month, depending on the specific product and dose. Novo and Lilly have escalated a GLP-1 pricing war over the last year, especially following the landmark “most favored nation” deals they struck with President Donald Trump in November.
The move also coincides with new, lower Medicare prices going into effect for Novo’s obesity and diabetes drugs in 2027 following negotiations with the federal government under the Inflation Reduction Act. The new negotiated prices for Wegovy, Ozempic and Rybelsus will be $274 per month.
Business
UP hikes minimum wages across categories amid Noida protest: What workers will now earn – The Times of India
The Uttar Pradesh government on Tuesday approved an interim hike of around 21% in minimum wages for workers in Gautam Buddh Nagar and Ghaziabad, following large-scale protests by thousands of factory workers in Noida. The fresh minimum wage structure introduced across worker categories, will be taking effect retrospectively from April 1. The agitation, which had been intensifying over several days, saw an estimated 40,000 to 45,000 workers assemble at nearly 80 to 83 locations across the Gautam Buddh Nagar commissionerate, including key industrial hubs such as Sector 62, Phase-2, Sector 63, Sector 60, Sector 84 and parts of Greater Noida. The revised wages were finalised by the high-powered committee and received approval late on Monday night. Gautam Buddh Nagar District Magistrate Medha Roopam said, “The wage increase has been done by the high-powered committee… The decision was approved by CM UP late last night.”
Breakdown: Who gets what
Gautam Buddh Nagar and GhaziabadThese regions have seen the sharpest revision:
- Unskilled workers will now be paid Rs 13,690 per month, up from Rs 11,313.
- Semi-skilled workers will receive Rs 15,059.
- Skilled workers will earn Rs 16,868 per month.
Other municipal corporation areas
- The new monthly wages stand at Rs 13,006 for unskilled workers.
- Semi-skilled workers will now earn Rs 14,306 every month.
- Skilled workers will be paid Rs 16,025.
In other districts
- Unskilled workers will now get Rs 12,356 per month.
- Semi-skilled workers will earn Rs 13,591.
- Skilled workers will see Rs 15,224 per month.
Additionally, Uttar Pradesh CM Yogi Adityanath has urged employers to ensure timely wage payments, provide appropriate overtime compensation, and guarantee weekly offs, bonuses and social security benefits, while also maintaining safe working conditions, especially for female workersThe wage revision comes after widespread protests by factory workers in Noida on Monday, where thousands raised demands for better pay and working conditions. Clashes broke out in parts of the district during the demonstrations, after which the government set up a committee to step in and facilitate discussions between workers and employers.The government said that it had assessed all feedback and objections before finalising the revision, aiming for the “balanced and practical” outcome.As per the official statement, the committee is working to resolve the issue through dialogue and coordination while considering measures to address industries dealing with global headwinds, including rising input costs and falling exports, even as workers’ demands on wages, overtime, safety and working conditions remain “relevant and important.”It further added that an interim wage revision linked to indexation is under consideration, and that the process for final wage determination will be taken up based on recommendations of a wage board to be formed soon.At the same time, the government rejected as “fake and misleading” social media claims suggesting a uniform minimum wage of Rs 20,000 per month, clarifying that no such order has been issued and that work on fixing a national “floor wage” is still underway at the central level.
Business
Oil prices ease on hopes of new US-Iran peace talks
Crude prices fall back below $100 a barrel as markets hope an agreement can be reached between the two sides.
Source link
Business
PSX surges over 4,000 points on hopes of US-Iran talks resumption | The Express Tribune
Broad-based rally fuelled by de-escalation hopes as investors turn optimistic about global peace
KARACHI:
The Pakistan Stock Exchange (PSX) opened on a distinctly bullish note as a renewed whisper of global calm set the tone for trading on Tuesday. The benchmark KSE-100 Index surged sharply in early hours, reflecting a wave of optimism among investors. At 9:39am, the index was hovering around 164,322.07, with gains of 3,730.74 points or 2.32%. It was then trading at 164,782.58, advancing with 4,191.25 points, or 2.61% at 12:34pm.
The rally follows growing expectations of a possible resumption of diplomatic talks between the United States and Iran, reviving hopes of de-escalation in a conflict that has shaken global financial markets.
The shift in sentiment comes in stark contrast to the previous session, where the market endured heavy losses amid failed negotiations and a spike in oil prices, triggering widespread panic selling across sectors.
Today, however, investors appear to be pricing in a different narrative – one where diplomacy may yet prevail. The prospect of renewed dialogue has eased concerns over supply disruptions and runaway energy prices, both critical variables for Pakistan’s import-heavy economy.
Read: PSX plunges over 6,600 points as US-Iran talks end without deal
Early gains were broad-based, led by index-heavy sectors such as automobile assemblers, cement, commercial banks, fertiliser, oil and gas exploration companies, OMCs, power generation and refinery, as participants moved to rebuild positions after the recent sell-off.
The sharp rebound underscores the market’s sensitivity to geopolitical signals, where even tentative progress towards peace can ignite strong bullish momentum.
Despite the upbeat start, analysts caution that volatility may persist, with much depending on whether diplomatic efforts translate into concrete outcomes. “Investors are optimistic about the likely resumption of talks between the US and Iran,” AKD Securities Director Research Mohammed Awais Ashraf told The Express Tribune.
Timely affirmation from Saudi Arabia and Qatar to bridge the gap in external financing to be created by the payment of UAE $3.5 billion this month and higher imports due to elevated oil prices have also helped to uplift the sentiment, he added. This is also likely to help in the timely approval of a $1.2 billion disbursement from the International Monetary Fund (IMF) after the approval of its executive board, Ashraf predicted.
-
Fashion7 days agoIndia’s exports face reset as EU links trade to carbon metrics: EY
-
Entertainment6 days agoQueen Elizabeth II emotional message for Archie, Lilibet sparks speculation
-
Tech6 days agoAs the Strait of Hormuz Reopens, Global Shipping Will Take Months to Recover
-
Tech6 days agoAzure customers up in arms over ‘full’ UK South region | Computer Weekly
-
Entertainment1 week agoLamar Odom shocking response to Khloé Kardashian account of his overdose
-
Sports1 week agoWith Messi goal, Inter Miami open new stadium with dream moment
-
Tech5 days agoThis AI Button Wearable From Ex-Apple Engineers Looks Like an iPod Shuffle
-
Fashion6 days agoCII submits 20-pt agenda to Indian govt to back firms hit by Iran war
